More Likely to 5X First: Johnson & Johnson vs. Vertex Pharmaceuticals
Racking up a five-bagger investment -- when one of your holdings grows by 5x -- is quite the accomplishment, and finding potential five-baggers is a great way to set your portfolio up for success.
On that note, powerful pharmaceutical businesses like Johnson & Johnson (NYSE: JNJ) and Vertex Pharmaceuticals (NASDAQ: VRTX) are stable enough and profitable enough to 5x, and they've both done it before. But which of these competitors has the hustle to become a five-bagger faster? Let's do some quick math to see how realistic it is for each company, then later we'll compare the results.
Johnson & Johnson's market capitalization is around $461 billion, making it one of the largest businesses in the world. To grow five times its current market cap, it would need to reach a market cap of more than $2.3 trillion.
Source Fool.com
